Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2016 | 2 |
2017 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Virological efficacy of PI monotherapy for HIV-1 in clinical practice.
J Antimicrob Chemother. 2016 Nov;71(11):3228-3234. doi: 10.1093/jac/dkw265. Epub 2016 Jul 7.
J Antimicrob Chemother. 2016.
PMID: 27402006
Free PMC article.
Wide variation in susceptibility of transmitted/founder HIV-1 subtype C Isolates to protease inhibitors and association with in vitro replication efficiency.
Sutherland KA, Collier DA, Claiborne DT, Prince JL, Deymier MJ, Goldstein RA, Hunter E, Gupta RK.
Sutherland KA, et al.
Sci Rep. 2016 Nov 30;6:38153. doi: 10.1038/srep38153.
Sci Rep. 2016.
PMID: 27901085
Free PMC article.
Item in Clipboard
Virological Outcomes of Second-line Protease Inhibitor-Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis.
Collier D, Iwuji C, Derache A, de Oliveira T, Okesola N, Calmy A, Dabis F, Pillay D, Gupta RK; French National Agency for AIDS and Viral Hepatitis Research (ANRS) 12249 Treatment as Prevention (TasP) Study Group.
Collier D, et al.
Clin Infect Dis. 2017 Apr 15;64(8):1006-1016. doi: 10.1093/cid/cix015.
Clin Infect Dis. 2017.
PMID: 28329393
Free PMC article.
Item in Clipboard
Cite
Cite